A Phase II Study of Pegfilgrastim (Neulasta) and Darbepoetin Alfa (Aranesp) in Support of Dose-Dense Adjuvant Chemotherapy for Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2013
At a glance
- Drugs Darbepoetin alfa (Primary) ; Pegfilgrastim (Primary) ; Cyclophosphamide; Doxorubicin; Paclitaxel
- Indications Breast cancer
- Focus Adverse reactions
- 03 Apr 2009 New trial record
- 01 May 2007 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.